MVMD Community Updates

Updates from our President & CEO to MVMD info subscribers.

MVMD Updates
Investor Relations:
Contact Us
416.738.7683
IR@Mountainvalleymd.com
Write to us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
January 14, 2021
//
MVMD Community Updates

MVMD Awarded Canadian Patent for Quicksome™ Technology

January 14, 2021
//
MVMD Community Updates

Mike Farber Interview on Quicksome™ Patent

January 13, 2021
//
MVMD Community Updates

MVMD – We Can’t Wait Any Longer!

January 11, 2021
//
MVMD Community Updates

Media Release – MVMD Applies for OTCQB Market Listing in U.S.

January 8, 2021
//
MVMD Community Updates

MVMD Update & Happy New Year!

December 24, 2020
//
MVMD Community Updates

MVMD Files for Acceleration of Patent Examination

December 22, 2020
//
MVMD Community Updates

New MVMD CEO Interview, Oversubscription of Private Placement

December 18, 2020
//
MVMD Community Updates

MVMD Interview Update - Mike Farber, Director of Life Sciences

December 16, 2020
//
MVMD Community Updates

MVMD CEO Interview on Proactive Investor this Morning

December 14, 2020
//
MVMD Community Updates

MVMD Advisory Board Growth and Strategic Investment

December 10, 2020
//
MVMD Community Updates

MUST WATCH – ARE YOU WITH US? MVMD: Infinite Possibility

December 10, 2020
//
MVMD Community Updates

What a Crazy 24 Hours – New Media Release!

December 9, 2020
//
MVMD Community Updates

MUST WATCH (video link) - Ivermectin Validation in COVID-19 Therapies!

December 5, 2020
//
MVMD Community Updates

Exciting Times for You and Mountain Valley MD…

November 25, 2020
//
MVMD Community Updates

MVMD Secures Quicksome™ License Agreement with Mushroom Partner and Strategic Sale of Subsidiary

November 11, 2020
//
MVMD Community Updates

Mountain Valley MD confirms major breakthrough in solubilizing ivermectin, files patents to protect IP and related COVID-19 applications

October 2, 2020
//
MVMD Community Updates

Mountain Valley MD confirms successful Quicksome™ dosing in pre-clinical trial for the drug ivermectin

Subscribe for Updates

Stay plugged in on everything Mountain Valley MD.

THANK YOU FOR YOUR INTEREST IN OUR STORY.
Please check your inbox to confirm your subscription.
Oops! Something went wrong while submitting the form.
*By Clicking "Sign Up" You agree to Mountain Valley MD's Privacy Policy
Subscribe